Cite

HARVARD Citation

    Arora, N. et al. (2008). Bevacizumab demonstrates activity in advanced refractory fallopian tube carcinoma. International journal of gynecological cancer. 18 (2), pp. 369-372. [Online]. 
  
Back to record